Trying to learn how to translate from the human translation examples.
From professional translators, enterprises, web pages and freely available translation repositories.
konjugeeritud pneumokokk- sahhariidvaktsiin, adsorbeeritud
prevenar suspension for injection in pre-filled syringe pneumococcal saccharide conjugated vaccine, adsorbed
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
pneumokokk-polüsahhariidi konjugaatvaktsiin (adsorbeeritud)
pneumococcal polysaccharide conjugate vaccine (adsorbed)
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
konjugeeritud pneumokokk-sahhariidvaktsiin, adsorbeeritud intramuskulaarne
pneumococcal saccharide conjugated vaccine, adsorbed intramuscular use.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
pneumokokk-polüsahhariidi serotüüpi 11,2 1 mikrogramm
pneumococcal polysaccharide serotype 11,2 1 microgram
Last Update: 2017-04-26
Usage Frequency: 6
Quality:
prevenar süstesuspensioon konjugeeritud pneumokokk- sahhariidvaktsiin, adsorbeeritud
prevenar suspension for injection pneumococcal saccharide conjugated vaccine, adsorbed
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
prevenar süstesuspensioon konjugeeritud pneumokokk- sahhariidvaktsiin, adsorbeeritud intramuskulaarne
prevenar suspension for injection pneumococcal saccharide conjugated vaccine, adsorbed intramuscular use.
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
prevenar süstesuspensioon süstelis konjugeeritud pneumokokk- sahhariidvaktsiin, adsorbeeritud intramuskulaarne
intramuscular use.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
synflorix süstesuspensioon mitmeannuselises konteineris pneumokokk-polüsahhariidi konjugaatvaktsiin (adsorbeeritud)
synflorix suspension for injection in multidose container pneumococcal polysaccharide conjugate vaccine (adsorbed)
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
kuni 18-aastaseid patsiente tuleb vaktsineerida haemophilus influenzae ja pneumokokk- infektsioonide vastu.
patients less than 18 years of age must be vaccinated against haemophilus influenzae and pneumococcal infections.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
invasiivse pneumokokk-haiguse esinemissageduse langus vanematel lastel võib olla osaliselt seotud loomuliku omandatud immuunsuse kujunemisega.
the decrease in the incidence of ipd seen in older children may be partly due to naturally acquired immunity.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
pneumokokk-vaktsiin, mida manustati 6 nädalat pärast raptiva-ravi lõpetamist, andis normaalsed tulemused.
a pneumococcal vaccine administered 6 weeks after discontinuation of raptiva yielded normal results.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
pneumokokk on hingamisteede bakternakkuste, näiteks kopsu-, keskkõrva- ja kõrvalurgete põletike peamine põhjustaja kõikides vanuserühmades.
pneumococci are the main cause of bacterial respiratory tract infections, such as pneumonia, middle ear infection, and sinusitis, in all age groups.
Last Update: 2014-06-03
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
pneumokokk-tekkene(sed) invasiivne(sed) haigus(ed) (streptococcus pneumoniae)
pneumococcal invasive disease(s) (streptococcus pneumoniae)
Last Update: 2014-11-21
Usage Frequency: 1
Quality:
intervall konjugeeritud pneumokokkvaktsiini (prevenar) ja 23-valentse pneumokokk-polüsahhariidvaktsiini manustamise vahel ei tohi olla lühem kui 8 nädalat.
the interval between the pneumococcal conjugate vaccine (prevenar) and the 23- valent pneumococcal polysaccharide vaccine should not be less than 8 weeks.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
euroopa 2- kuni 5-aastastel lastel katab prevenar umbes 62% kuni 83% invasiivset pneumokokk-haigust põhjustavatest kliinilistest isolaatidest.
in european children between 2 to 5 years of age, prevenar should cover about 62 % to 83 % of the clinical isolates responsible for invasive pneumococcal disease.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
kui see on soovitatav, peaks kõrge riskiga 24 kuulisi lapsi, keda on varasemalt vaktsineeritud prevenar’iga, vaktsineerima 23-valentse pneumokokk-polüsahhariidvaktsiiniga.
whenever recommended, children at risk who are ≥ 24 months of age and already primed with prevenar should receive 23-valent pneumococcal polysaccharide vaccine.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
Ülejäänud 1816 last osalesid uuringutes, kus procomvax’i manustati samaaegselt uurimisjärgus pneumokokk- polüsahhariid-valgukonjugaatvaktsiiniga või uurimisjärgus difteeria, teetanuse, läkaköha ja inaktiveeritud poliomüeliidi vaktsiiniga, ning neid jälgiti tõsiste kõrvaltoimete suhtes.
the remaining 1,816 infants were involved in trials where procomvax was administered concomitantly with either an investigational pneumococcal polysaccharide protein conjugate vaccine or an investigational preparation of diphtheria, tetanus, pertussis, and inactivated poliovirus vaccine and were under surveillance for serious adverse experiences.
Last Update: 2017-04-26
Usage Frequency: 3
Quality: